Sign up to save your podcasts
Or
Share JAK-STAT Signaling and Disease Pathogenesis in RA and IBD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAK-STAT Signaling and Disease Pathogenesis in RA and IBD
CME credits: 0.25
Valid until: 29-10-2019
Claim your CME credit at https://reachmd.com/programs/cme/jak-stat-signaling-and-disease-pathogenesis-in-ra-and-ibd/10440/
With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 29-10-2019
Claim your CME credit at https://reachmd.com/programs/cme/jak-stat-signaling-and-disease-pathogenesis-in-ra-and-ibd/10440/
With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.